Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.rpglifesciences.com | |
Market Cap | 1,319.40 Cr. | |
Enterprise Value(EV) | 1,262.37 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 40.90 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 19.51 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 33.51 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 185.99 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 4.29 | Calculated using Price: 797.75 |
Dividend Yield | 1.50 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.65 Cr. | 16,539,015 Shares |
FaceValue | 8 | |
About RPG Life Sciences Ltd. | ||
RPG Life Sciences (RPGLS) is a pharmaceutical organization and was formerly known as Searle (India) Limited. It is a full spectrum world class, customer focussed, innovative pharmaceutical organisation. RPGLS started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to the RPG Group. The company's name was changed to RPG Life Sciences Ltd effective April 1, 1999.This company belongs to RPG group |
1 Day |
|
+0.49% |
1 Week |
|
+5.48% |
1 Month |
|
+2.28% |
3 Month |
|
+0.75% |
6 Month |
|
-8.04% |
1 Year |
|
+55.34% |
2 Year |
|
+81.86% |
5 Year |
|
+153.84% |
10 Year |
|
+1127.59% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 52.87 | 0.80 | 8.98 | 14.98 | 8.91 | 6.86 | 17.21 | 20.36 | 21.80 | |
Return on Capital Employed (%) | 48.37 | 2.50 | 8.97 | 15.58 | 12.52 | 9.81 | 20.35 | 27.27 | 31.46 | |
Return on Assets (%) | 25.50 | 0.47 | 5.34 | 9.15 | 5.17 | 4.07 | 11.25 | 14.00 | 15.89 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 126 | 125 | 134 | 147 | 155 | 161 | 177 | 216 | 256 | 308 | |
Non Curr. Liab. | 7 | 20 | 22 | 11 | 8 | 10 | 9 | 7 | 9 | 9 | |
Curr. Liab. | 77 | 67 | 67 | 79 | 121 | 78 | 83 | 80 | 80 | 103 | |
Minority Int. | |||||||||||
Equity & Liab. | 209 | 212 | 223 | 236 | 284 | 248 | 268 | 303 | 345 | 419 | |
Non Curr. Assets | 112 | 126 | 136 | 140 | 141 | 151 | 142 | 127 | 138 | 155 | |
Curr. Assets | 97 | 86 | 87 | 96 | 143 | 97 | 126 | 176 | 207 | 264 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 209 | 212 | 223 | 236 | 284 | 248 | 268 | 303 | 345 | 419 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 236 | 242 | 279 | 294 | 344 | 330 | 376 | 389 | 440 | 513 | |
Other Income | 3 | 7 | 2 | 10 | 2 | 1 | 1 | 1 | 3 | 5 | |
Total Income | 238 | 249 | 281 | 303 | 346 | 331 | 377 | 390 | 443 | 518 | |
Total Expenditure | -224 | -234 | -257 | -265 | -307 | -296 | -316 | -318 | -353 | -410 | |
PBIDT | 14 | 15 | 24 | 38 | 39 | 35 | 61 | 72 | 90 | 107 | |
Interest | -3 | -3 | -2 | -4 | -5 | -5 | -3 | -2 | -1 | 0 | |
Depreciation | -11 | -11 | -10 | -11 | -14 | -15 | -16 | -16 | -16 | -16 | |
Taxation | -12 | -2 | -7 | -4 | -7 | -14 | -22 | -24 | |||
Exceptional Items | 64 | -5 | |||||||||
PAT | 53 | 1 | 12 | 21 | 13 | 11 | 29 | 40 | 51 | 68 | |
Adjusted EPS | 32 | 1 | 7 | 13 | 8 | 7 | 18 | 24 | 31 | 41 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 12 | -6 | -2 | 33 | 7 | 15 | 46 | 50 | 58 | 65 | |
Cash Fr. Inv. | -12 | 59 | -10 | -15 | -30 | -16 | -19 | -11 | -8 | -35 | |
Cash Fr. Finan. | 0 | -54 | 12 | -18 | 23 | 0 | -27 | -39 | -10 | -14 | |
Net Change | 0 | 0 | 0 | 1 | -1 | 0 | 0 | 40 | 17 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 40 | 57 |
Tue, 30 May 2023
Loss of Share Certificates
|
|
Fri, 26 May 2023
Annual Secretarial Compliance Report
|
|
Thu, 25 May 2023
Annual Secretarial Compliance Report
|
Mon, 05 Jun 2023 |
|
|
|
|
|